The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Essex Woodlands Health Ventures Fund Vi L P since 2007.
The trader's CIK number is 1276801.
At the time of the last reporting, Essex Woodlands Health Ventures Fund Vi L P was the 10% Owner of Ziopharm Oncology Inc. (stock ticker symbol ZIOP).
Also see all insider trading activities at Ziopharm Oncology Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | ZIOP | 457,766 | $999,897 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | LJPC | 0 | $0 | 9,748,644 | $727,553 | 0 | $0 |
| 2008 | LJPC | 2,081,977 | $3,934,936 | 0 | $0 | 0 | $0 |
| 2007 | LJPC | 1,000,000 | $6,000,000 | 0 | $0 | 0 | $0 |
1. Ziopharm Oncology Inc (ZIOP)
2. La Jolla Pharmaceutical Co (LJPC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-12-08 | ZIOP | Buy | 129,000 | 3.10 | 399,900 |
| 2009-09-15 | ZIOP | Buy | 328,766 | 1.82 | 599,997 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-08-06 | LJPC | Sale | 368,872 | .18 | 67,503 |
| 2009-08-05 | LJPC | Sale | 792,942 | .19 | 148,280 |
| 2009-02-26 | LJPC | Sale | 4,236,586 | .05 | 216,065 |
| 2009-02-25 | LJPC | Sale | 2,186,211 | .06 | 137,731 |
| 2009-02-24 | LJPC | Sale | 2,164,033 | .07 | 157,974 |
| 2008-05-12 | LJPC | Buy | 2,081,977 | 1.89 | 3,934,936 |
| 2007-04-04 | LJPC | Buy | 1,000,000 | 6.00 | 6,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Essex Woodlands Health Ventures Fund Vi L P (10% Owner of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.